ArticleAdvanced therapeutics2022

A single-dose Qβ VLP vaccine against S100A9 protein reduces atherosclerosis in a preclinical model.

Oscar A Ortega-Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.